Cryo-Cell International (CCEL) Stock Statistics & Valuation Metrics

Cryo-Cell International has a market cap or net worth of $40.30M. The enterprise value is $48.21M.

Cryo-Cell International has 8,057,150 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cryo-Cell International’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is 1.05%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Cryo-Cell International had revenue of 31.99M and earned 402.10K in profits. Earnings per share was 0.05.

In the last 12 months, operating cash flow was 6.26M and capital expenditures -585.18K, giving a free cash flow of 5.67M billion.

Cryo-Cell International pays an annual dividend of $0.65, resulting in a dividend yield of 8%

Cryo-Cell International upcoming earnings date is Oct 10, 2025, TBA (Confirmed).

Cryo-Cell International as a current ratio of 0.58, with Debt / Equity ratio of -58.79%

In the past 12 months, Cryo-Cell International has paid 2.40M in taxes.

Cryo-Cell International EV to EBITDA ratio is 58.23, with an EV/FCF ratio of 22.97.

Cryo-Cell International has $4.43M in cash and marketable securities with $9.15M in debt, giving a net cash position of $4.72M billion.

Gross margin is 76.23%, with operating margin of 10.88%, and net profit margin of 1.26%.

The average price target for Cryo-Cell International is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy